Clinical trial
Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
NCT05119036 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
- Lead sponsor
- Indiana University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 12, 2022
- Completion date
- July 13, 2026
- Enrollment
- 82 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hpv positive oropharyngeal squamous cell carcinoma, squamous cell carcinoma of the oropharynx